CClinicalTrials.gg
CompletedNCT05714696Updated May 15, 2025Results posted

Weight Discrimination and Poor Cardiovascular Health

An interventional study of Weight discrimination experience and Control experience in Obesity, sponsored by Florida State University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-15.

Sponsored by Florida State University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
333
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

People with obesity regularly experience discrimination on the basis of their body weight and such experiences are associated with increased risk for poor cardiovascular health. The goal of this clinical trial is to identify cognitive, affective, behavioral, and physiological factors that explain the relationship between weight discrimination and poor health outcomes.

A diverse sample of adults with obesity will be randomly assigned to a social interaction encounter that simulates a typical weight discrimination experience (experimental manipulation) vs. a control manipulation that does not involve discrimination. The investigators will examine the immediate effects of the experimental manipulation on cognitive (e.g., self-regulation), affective (e.g., negative emotion), behavioral (e.g., comfort eating), and physiological (e.g., cortisol secretion) outcomes.

Two additional aims of the study are to identify psychological traits that moderate responses to weight discrimination and to assess whether the negative health effects of weight discrimination differ by age, sex/gender, race, or ethnicity.

Read the detailed description

Discrimination is a critical social determinant of health that underlies poor health outcomes. One common but understudied form of discrimination is weight discrimination. Weight discrimination is the behavioral manifestation of weight stigma-the social devaluation of people with excess body weight. Findings suggest that the stress produced by weight discrimination prompts weight gain, creating a vicious cycle between weight discrimination and obesity. Further, there is now well-documented evidence that experiencing weight discrimination is associated with increased risk for cardiovascular disease. Little is known, however, about mechanisms explaining the link between weight discrimination and poor cardiovascular health. Using a rigorous experimental approach, this project will identify mechanisms through which weight discrimination harms health. Findings will facilitate the long-term goal of this research: interventions to decrease the negative health consequences of weight discrimination.

As a step toward this goal, this project proposes to conduct an experiment in which a diverse sample of adults with obesity will be randomly assigned to experience (vs. not experience) weight discrimination in a controlled experimental setting. Drawing on previous research and the investigators' pilot data, the interpersonal context chosen for the study simulates situations in which people with obesity commonly experience weight discrimination in their daily lives (e.g., employment settings).

The study will involve two parts: a pre-session baseline survey and an experimental session that will take place in the lab. The baseline survey will be completed online and will assess individual difference variables/psychological variables and demographic characteristics. The in-person lab visit will take place on campus about one week after completion of the baseline survey. The study manipulation (i.e., intervention) will be delivered during the lab visit. Primary outcome variables will be assessed during the lab visit, after delivery of the intervention.

The following aims will be tested: (1) Identify early-stage cognitive, affective, behavioral, and physiological mechanisms activated by experimentally manipulated weight discrimination; (2) Identify psychological variables (e.g., internalized weight bias) that moderate effects of weight discrimination; and (3) Identify demographic characteristics (e.g., gender, race) that moderate effects of weight discrimination. Exposure to weight discrimination (vs. control) is hypothesized to result in elevated responses on early-stage mechanisms that culminate in poor cardiovascular health (e.g., impaired self-regulation, higher negative emotion, more social withdrawal and comfort eating, increased cortisol secretion). This research will identify novel and highly modifiable targets for interventions designed to reduce the negative health effects of weight discrimination. In testing moderator variables, this work will identify individuals who display vulnerability vs. resilience to the harmful effects of discrimination. Information about moderators will thus help future intervention efforts target those individuals most likely to benefit from intervention. Given the high prevalence of obesity and the millions of Americans affected by weight discrimination, this research will address a crucial public health issue.

02

Conditions studied

  • Obesity
03

In context

Lead sponsor

Florida State University is the lead sponsor of 241 studies on the registry; 46 are open to participants now.

Of its 15 completed or terminated interventional studies of FDA-regulated products, 9 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • (1) body mass index (BMI) greater than or equal to 30 (units: weight in kilograms divided by height in meters squared; BMI criteria for obesity)
  • (2) 18 years of age or older
  • (3) able to read and understand English
  • (4) have Internet access (to complete the baseline survey)
  • (5) able to come to FSU's campus to take part in a lab-based study

Exclusion criteria

Exclusion Criteria:

  • (1) having participated in any of our pilot studies on weight stigma
  • (2) diagnosed with a current major psychiatric disorder (e.g., major depressive disorder, eating disorder)
  • (3) pregnant or nursing
  • (4) diagnosed with Cushing syndrome or taking steroid-based medications
  • (5) having allergies to ingredients in the foods being offered during the taste test (e.g., gluten, peanuts).
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
333 participants (actual)

Study arms

  • Experimental
    Weight discrimination experience

    Participants in the experimental condition will: 1. Learn that their group mates are biased against overweight people (i.e., they have negative attitudes toward people with higher body weight), 2. Receive feedback about their personal attributes that is consistent with negative weight-based stereotypes (e.g., lacking self-discipline), and 3. Not be selected as a partner for the remaining lab tasks (i.e., this experience may prompt feelings of social exclusion).

    Behavioral: Weight discrimination experience

  • Active comparator
    Control experience

    Participants in the control condition will: 1. Learn that their group mates are very accepting of overweight people (i.e., they have positive attitudes toward people with higher body weight), 2. Receive positive feedback about their personal attributes that is not consistent with negative weight-based stereotypes, and 3. Will be told that one of their group members had to leave early for an emergency so the pairs cannot be assembled as usual (i.e., this experience should not prompt feelings of social exclusion).

    Behavioral: Control experience

Interventions

  • BehavioralWeight discrimination experience

    In the experimental condition, participants will learn that their group members are biased against overweight people but not elderly or racial/ethnic minority individuals, as indicated by the "getting to know you" summary ratings handout. Participants will also receive negative feedback about their personal attributes by being labeled with negative weight-based stereotypes. Although some ratings will be positive (e.g., they will receive high ratings on being friendly and kind), participants will be rated poorly on attributes viewed as necessary to develop a strong marketing campaign (i.e., motivation to work hard, possessing self-discipline to persist at the task, and competence). After (ostensibly) assembling the group's preferences, the experimenter will inform participants that no one selected them to be their partner, thus they will perform the next few tasks alone. This manipulation has been shown to prompt feelings of social exclusion.

  • BehavioralControl experience

    In the control condition, participants will learn that their group members have positive attitudes toward people with higher body weight, as well as elderly and racial/ethnic minority individuals, as indicated by the "getting to know you" summary ratings handout. Participants will also receive positive feedback about their personal attributes, as indicated by the summary ratings averaged across the three members. Finally, participants in the control condition will be told that one of their group members had to leave unexpectedly for a family emergency, so pairs cannot be assembled as usual, thus they will perform the next few tasks alone. This manipulation should not prompt feelings of social exclusion.

06

What researchers measure

Primary outcomes

  1. Negative Affect

    A modified version of the Positive and Negative Affect Scale-Expanded Form (PANAS-X) will be used to assess emotions in response to the experimental manipulation. The scale demonstrates good validity and reliability. Emotions will be assessed with 46 adjectives (e.g., angry, confident) by indicating the extent to each emotion is felt at that moment (1=very slightly or not at all to 5=extremely). A composite score for negative affect will be created by taking the average of the relevant adjectives. Scores will range from 1 to 5, with higher scores indicating more negative emotion.

    Time frame: 2 minutes after delivery of the intervention

  2. Positive Affect

    A modified version of the Positive and Negative Affect Scale-Expanded Form (PANAS-X) will be used to assess emotions in response to the experimental manipulation. The scale demonstrates good validity and reliability. Emotions will be assessed with 46 adjectives (e.g., angry, confident) by indicating the extent to each emotion is felt at that moment (1=very slightly or not at all to 5=extremely). A composite score for positive affect will be created by taking the average of the relevant adjectives. Scores will range from 1 to 5, with higher scores indicating more positive emotion.

    Time frame: 2 minutes after delivery of the intervention

  3. Self-efficacy for Weight Control Behavior

    Self-efficacy (perceived confidence) in one's ability to engage in weight control behaviors (e.g., dietary restraint, physical activity) over the next six months will be assessed. Self-efficacy for dietary restraint will be assessed with the short form of the Weight Efficacy Lifestyle Questionnaire (e.g., I can resist eating ... when I am depressed or down; 8 items). Self-efficacy for physical activity will be assessed with the Exercise Self-efficacy Scale (e.g., I am confident I can participate in regular exercise when ... I am tired; 5 items). Weight control items will be interspersed with items assessing self-efficacy for other health behaviors (e.g., flu vaccination, sleep). Each item will be rated on an 8-point scale (0=not at all confident to 7=very confident). Items will be averaged to create a composite score. Scores will range from 0 to 7, with higher scores indicating higher self-efficacy for weight control behavior.

    Time frame: 6 minutes after delivery of the intervention

  4. Intentions for Weight Control Behavior

    Using the same health behaviors assessed for self-efficacy, intentions for weight control behavior will be assessed (i.e., intentions to engage in each behavior over the next six months). Each item will be rated on an 8-point scale (0=strongly disagree to 7=strongly agree). Items will be averaged to create a composite score. Scores will range from 0 to 7, with higher scores indicating higher intentions to engage in weight control behavior.

    Time frame: 10 minutes after delivery of the intervention

  5. Executive control_accuracy

    The Stroop task provides a measure of executive control by assessing the ability to inhibit an automatic response (reading) in favor of performing a more controlled task (color naming). The task is a classic, widely used and well-validated measure of executive control. Eight blocks of 20 trials will be performed that will take approximately 5 minutes to complete. Executive control scores will be calculated for response accuracy and speed. Metric: accuracy (percentage of correct answers on mismatched trials). A lower percentage of correct answers on mismatched trials indicates worse executive control.

    Time frame: 15 minutes after delivery of the intervention

  6. Executive control_speed

    The Stroop task provides a measure of executive control by assessing the ability to inhibit an automatic response (reading) in favor of performing a more controlled task (color naming). The task is a classic, widely used and well-validated measure of executive control. Eight blocks of 20 trials will be performed that will take approximately 5 minutes to complete. Executive control scores will be calculated for accuracy and speed (reaction time). Metric: reaction time (average reaction time in milliseconds on mismatched trials). Longer reaction times on mismatched trials indicate worse executive control.

    Time frame: 15 minutes after delivery of the intervention

  7. Delay Discounting

    Delay discounting involves the subjective depreciation of an incentive based on its timing. The measure assesses the ability to delay gratification, that is, a tendency to prioritize larger long-term rewards over smaller short-term rewards. The task involves choosing short vs. long-term rewards from a set of five dichotomous choices (e.g., to receive $1 immediately or $10 in one month). The task takes about 1 minute to administer, is highly reliable, and correlates well with longer and more extensive measures of delay discounting (metric: discount rate (k)). Scores will range from 0.000110 to 24, with higher scores indicating more impulsivity/lower ability to delay gratification.

    Time frame: 20 minutes after delivery of the intervention

  8. Change in Cortisol From Baseline to First Follow-up Assessment

    The investigators will measure cortisol secretion via saliva (passive drool) 25 minutes after delivery of the intervention (first follow-up) and compare it to baseline cortisol levels.

    Time frame: 25 minutes after delivery of the intervention

  9. Comfort Eating

    Comfort eating will be assessed via an eating task to objectively measure hyper-palatable (high-fat, -sodium, -sugar, and -carbohydrate) food intake. To avoid floor effects, the eating task will take place under the guise of a faux taste test, which will ostensibly guide the development of the food marketing campaign later during the study. To avoid ceiling effects and to allow eating behavior without fear that the experimenter will negatively judge the amount eaten, large quantities of each food will be made available. The task will take 10 minutes to complete and will be conducted in a private room. Bowls will be weighed (unobtrusively) before and after the task to compute the difference in grams, which will then be converted to kilocalories based on published nutrition information from the food maker. Higher kilocalorie consumption indicates a tendency to engage in more comfort eating during times of stress.

    Time frame: 30 minutes after delivery of the intervention

  10. Social Withdrawal

    Social withdrawal will be assessed with a measure from previous research. The experimenter will present three options for working on the final task: alone, with a former group member, or with a new partner. Choosing to work alone reflects a desire to avoid social interaction. Each response will be assigned a numerical code (work alone = 0; work with a former group member = 1; work with a new partner = 2). Scores of zero indicate a greater tendency to withdraw socially during times of stress.

    Time frame: 45 minutes after delivery of the intervention

  11. Change in Cortisol From Baseline to Second Follow-up Assessment

    The investigators will measure cortisol secretion via saliva (passive drool) 60 minutes after delivery of the intervention (second follow-up) and compare it to baseline cortisol levels.

    Time frame: 60 minutes after delivery of the intervention

07

Results

Posted May 15, 2025
Limitations and caveats
Because the of mechanism used to fund this project (R56), we received only one year of funding and thus we were not able to reach our desired sample size of 320 participants.

Participant flow

Participants were recruited from the local community between February 2023 and April 2024. The first participant was enrolled on February 5, 2023 and the last participant was enrolled on April 26, 2024.

Participant flow — Overall Study
MilestoneWeight Discrimination ExperienceControl Experience
Started136135
Completed136135
Not completed00

Outcome measures

PrimaryNegative Affect

A modified version of the Positive and Negative Affect Scale-Expanded Form (PANAS-X) will be used to assess emotions in response to the experimental manipulation. The scale demonstrates good validity and reliability. Emotions will be assessed with 46 adjectives (e.g., angry, confident) by indicating the extent to each emotion is felt at that moment (1=very slightly or not at all to 5=extremely). A composite score for negative affect will be created by taking the average of the relevant adjectives. Scores will range from 1 to 5, with higher scores indicating more negative emotion.

Time frame:
2 minutes after delivery of the intervention
Reported as:
Mean · score on a scale
Negative Affect
score on a scaleWeight Discrimination ExperienceControl Experience
Negative Affect1.43 ± 0.491.29 ± 0.33
Statistical analysis
  • Control Experience · t-test, 2 sided · p = .007
PrimaryPositive Affect

A modified version of the Positive and Negative Affect Scale-Expanded Form (PANAS-X) will be used to assess emotions in response to the experimental manipulation. The scale demonstrates good validity and reliability. Emotions will be assessed with 46 adjectives (e.g., angry, confident) by indicating the extent to each emotion is felt at that moment (1=very slightly or not at all to 5=extremely). A composite score for positive affect will be created by taking the average of the relevant adjectives. Scores will range from 1 to 5, with higher scores indicating more positive emotion.

Time frame:
2 minutes after delivery of the intervention
Reported as:
Mean · score on a scale
Positive Affect
score on a scaleWeight Discrimination ExperienceControl Experience
Positive Affect2.83 ± 0.943.04 ± 0.82
Statistical analysis
  • Control Experience · t-test, 2 sided · p = .049
PrimarySelf-efficacy for Weight Control Behavior

Self-efficacy (perceived confidence) in one's ability to engage in weight control behaviors (e.g., dietary restraint, physical activity) over the next six months will be assessed. Self-efficacy for dietary restraint will be assessed with the short form of the Weight Efficacy Lifestyle Questionnaire (e.g., I can resist eating ... when I am depressed or down; 8 items). Self-efficacy for physical activity will be assessed with the Exercise Self-efficacy Scale (e.g., I am confident I can participate in regular exercise when ... I am tired; 5 items). Weight control items will be interspersed with items assessing self-efficacy for other health behaviors (e.g., flu vaccination, sleep). Each item will be rated on an 8-point scale (0=not at all confident to 7=very confident). Items will be averaged to create a composite score. Scores will range from 0 to 7, with higher scores indicating higher self-efficacy for weight control behavior.

Time frame:
6 minutes after delivery of the intervention
Reported as:
Mean · score on a scale
Self-efficacy for Weight Control Behavior
score on a scaleWeight Discrimination ExperienceControl Experience
Self-efficacy for Weight Control Behavior4.29 ± 1.423.91 ± 1.42
Statistical analysis
  • Control Experience · t-test, 2 sided · p = .029
PrimaryIntentions for Weight Control Behavior

Using the same health behaviors assessed for self-efficacy, intentions for weight control behavior will be assessed (i.e., intentions to engage in each behavior over the next six months). Each item will be rated on an 8-point scale (0=strongly disagree to 7=strongly agree). Items will be averaged to create a composite score. Scores will range from 0 to 7, with higher scores indicating higher intentions to engage in weight control behavior.

Time frame:
10 minutes after delivery of the intervention
Reported as:
Mean · score on a scale
Intentions for Weight Control Behavior
score on a scaleWeight Discrimination ExperienceControl Experience
Intentions for Weight Control Behavior4.91 ± 1.304.70 ± 1.28
Statistical analysis
  • Control Experience · t-test, 2 sided · p = .163
PrimaryExecutive control_accuracy

The Stroop task provides a measure of executive control by assessing the ability to inhibit an automatic response (reading) in favor of performing a more controlled task (color naming). The task is a classic, widely used and well-validated measure of executive control. Eight blocks of 20 trials will be performed that will take approximately 5 minutes to complete. Executive control scores will be calculated for response accuracy and speed. Metric: accuracy (percentage of correct answers on mismatched trials). A lower percentage of correct answers on mismatched trials indicates worse executive control.

Time frame:
15 minutes after delivery of the intervention
Reported as:
Mean · percentage of correct responses
Executive control_accuracy
percentage of correct responsesWeight Discrimination ExperienceControl Experience
Executive control_accuracy96 ± 5.096 ± 4.7
Statistical analysis
  • Control Experience · t-test, 2 sided · p = .442
PrimaryExecutive control_speed

The Stroop task provides a measure of executive control by assessing the ability to inhibit an automatic response (reading) in favor of performing a more controlled task (color naming). The task is a classic, widely used and well-validated measure of executive control. Eight blocks of 20 trials will be performed that will take approximately 5 minutes to complete. Executive control scores will be calculated for accuracy and speed (reaction time). Metric: reaction time (average reaction time in milliseconds on mismatched trials). Longer reaction times on mismatched trials indicate worse executive control.

Time frame:
15 minutes after delivery of the intervention
Reported as:
Mean · milliseconds
Executive control_speed
millisecondsWeight Discrimination ExperienceControl Experience
Executive control_speed1191 ± 4291362 ± 492
PrimaryDelay Discounting

Delay discounting involves the subjective depreciation of an incentive based on its timing. The measure assesses the ability to delay gratification, that is, a tendency to prioritize larger long-term rewards over smaller short-term rewards. The task involves choosing short vs. long-term rewards from a set of five dichotomous choices (e.g., to receive $1 immediately or $10 in one month). The task takes about 1 minute to administer, is highly reliable, and correlates well with longer and more extensive measures of delay discounting (metric: discount rate (k)). Scores will range from 0.000110 to 24, with higher scores indicating more impulsivity/lower ability to delay gratification.

Time frame:
20 minutes after delivery of the intervention
Reported as:
Mean · score on a scale
Delay Discounting
score on a scaleWeight Discrimination ExperienceControl Experience
Delay Discounting0.86 ± 3.871.20 ± 4.78
Statistical analysis
  • Control Experience · t-test, 2 sided · p = .527
PrimaryChange in Cortisol From Baseline to First Follow-up Assessment

The investigators will measure cortisol secretion via saliva (passive drool) 25 minutes after delivery of the intervention (first follow-up) and compare it to baseline cortisol levels.

Time frame:
25 minutes after delivery of the intervention
Reported as:
Mean · ug/dL
Change in Cortisol From Baseline to First Follow-up Assessment
ug/dLWeight Discrimination ExperienceControl Experience
Change in Cortisol From Baseline to First Follow-up Assessment.0000 ± .0000.0076 ± .0874
Statistical analysis
  • Control Experience · t-test, 2 sided · p = .311
PrimaryComfort Eating

Comfort eating will be assessed via an eating task to objectively measure hyper-palatable (high-fat, -sodium, -sugar, and -carbohydrate) food intake. To avoid floor effects, the eating task will take place under the guise of a faux taste test, which will ostensibly guide the development of the food marketing campaign later during the study. To avoid ceiling effects and to allow eating behavior without fear that the experimenter will negatively judge the amount eaten, large quantities of each food will be made available. The task will take 10 minutes to complete and will be conducted in a private room. Bowls will be weighed (unobtrusively) before and after the task to compute the difference in grams, which will then be converted to kilocalories based on published nutrition information from the food maker. Higher kilocalorie consumption indicates a tendency to engage in more comfort eating during times of stress.

Time frame:
30 minutes after delivery of the intervention
Reported as:
Mean · kcals
Comfort Eating
kcalsWeight Discrimination ExperienceControl Experience
Comfort Eating299.42 ± 194.72365.73 ± 173.83
Statistical analysis
  • Control Experience · t-test, 2 sided · p = .004
PrimarySocial Withdrawal

Social withdrawal will be assessed with a measure from previous research. The experimenter will present three options for working on the final task: alone, with a former group member, or with a new partner. Choosing to work alone reflects a desire to avoid social interaction. Each response will be assigned a numerical code (work alone = 0; work with a former group member = 1; work with a new partner = 2). Scores of zero indicate a greater tendency to withdraw socially during times of stress.

Time frame:
45 minutes after delivery of the intervention
Reported as:
Count of participants · Participants
Social Withdrawal
ParticipantsWeight Discrimination ExperienceControl Experience
Work by self7255
Work with former group member2852
Work with new group member3627
Statistical analysis
  • Control Experience · Chi-squared · p = .005
PrimaryChange in Cortisol From Baseline to Second Follow-up Assessment

The investigators will measure cortisol secretion via saliva (passive drool) 60 minutes after delivery of the intervention (second follow-up) and compare it to baseline cortisol levels.

Time frame:
60 minutes after delivery of the intervention
Reported as:
Mean · ug/dL
Change in Cortisol From Baseline to Second Follow-up Assessment
ug/dLWeight Discrimination ExperienceControl Experience
Change in Cortisol From Baseline to Second Follow-up Assessment.0000 ± .0000.0000 ± .0000

Adverse events

Collected over 2 hours. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Weight Discrimination Experience0/136 (0%)0/136 (0%)0/136 (0%)
Control Experience0/135 (0%)0/135 (0%)0/135 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Weight Discrimination ExperienceControl ExperienceTotal
Mean37.99 ± 13.4138.70 ± 13.2838.34 ± 13.33
Sex/Gender, Customized
Sex/Gender, Customized(Participants)Weight Discrimination ExperienceControl ExperienceTotal
Female109108217
Male262652
Prefer not to answer011
Unknown101
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Weight Discrimination ExperienceControl ExperienceTotal
Hispanic or Latino161632
Not Hispanic or Latino120119239
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Weight Discrimination ExperienceControl ExperienceTotal
American Indian or Alaska Native112
Asian628
Native Hawaiian or Other Pacific Islander101
Black or African American434184
White7785162
More than one race5510
Unknown or Not Reported314
Region of Enrollment
Region of Enrollment(participants)Weight Discrimination ExperienceControl ExperienceTotal
United States136135271
Body mass index
Body mass index(kg/m2)Weight Discrimination ExperienceControl ExperienceTotal
Mean37.99 ± 6.9937.22 ± 5.7337.61 ± 6.39
08

Study locations

1 site
  • Florida State University
    Tallahassee, Florida 32306, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Oct 13, 2022
  • Informed consent form · Oct 13, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — The research team agrees to develop a transportable de-identified database, codebook, and mechanism by which data could be shared with other investigators upon approval of the PI.

Supporting information: Study protocol, Icf

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05714696
Lead sponsor
Florida State University
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Responsible party
Mary Gerend (Associate Professor, Florida State University) — Principal investigator
First posted
Feb 6, 2023
Start date
Feb 5, 2023
Primary completion
Apr 26, 2024
Completion
Apr 26, 2024
Results posted
May 15, 2025
Last update
May 15, 2025

Study contacts

Mary A Gerend, PhD
principal investigator · Florida State University, College of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion